Perrigo (PRGO) Amortization of Deferred Charges (2015 - 2026)
Perrigo (PRGO) posted quarterly Amortization of Deferred Charges of -$4.9 million for Q1 2026, up 23.44% year-over-year from -$4.0 million in Q1 2025, and up 10.91% quarter-over-quarter from -$5.5 million in Q4 2025.
Perrigo (PRGO) Amortization of Deferred Charges (2015 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Amortization of Deferred Charges for 6 consecutive years, with -$4.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Amortization of Deferred Charges rose 23.44% year-over-year to -$4.9 million; the TTM figure through Mar 2026 stood at -$35.7 million (up 4.29% YoY), while the FY2025 annual figure was -$23.8 million, down 135.64% from the prior year.
- Amortization of Deferred Charges grew to -$4.9 million in Q1 2026 per PRGO's latest filing, from -$5.5 million in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at -$4.9 million in Q1 2026 and bottomed at -$18.9 million in Q4 2024.
- Historically, Amortization of Deferred Charges has averaged -$8.9 million across 3 years, with a median of -$5.9 million in 2025.
- Annual changes were most pronounced in 2025 — Amortization of Deferred Charges surged 70.9% — and 2026, when it grew 23.44%.
- Perrigo's Amortization of Deferred Charges stood at -$18.9 million in 2024, then surged by 70.9% to -$5.5 million in 2025, then climbed by 10.91% to -$4.9 million in 2026.
- Business Quant data shows PRGO's Amortization of Deferred Charges at -$4.9 million in Q1 2026, -$5.5 million in Q4 2025, and -$6.4 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Perrigo | 1.93 Bn | 1.53 Bn | 313.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -5.40 Mn |
| Jun 27, 2026 | -5.40 Mn |
| Mar 28, 2026 | -4.90 Mn |
| Mar 28, 2026 | -4.90 Mn |
| Dec 31, 2025 | -5.50 Mn |
| Dec 31, 2025 | -5.50 Mn |
| Mar 29, 2025 | -6.40 Mn |
| Mar 29, 2025 | -6.40 Mn |
| Dec 31, 2024 | -18.90 Mn |
| Dec 31, 2024 | -18.90 Mn |
| Sep 30, 2017 | -6.60 Mn |
| Sep 30, 2017 | -6.60 Mn |
| Jul 1, 2017 | -5.40 Mn |
| Jul 1, 2017 | -5.40 Mn |
| Apr 1, 2017 | -6.40 Mn |
| Apr 1, 2017 | -6.40 Mn |
| Jul 2, 2016 | -9.40 Mn |
| Jul 2, 2016 | -9.40 Mn |
| Apr 2, 2016 | -6.70 Mn |
| Apr 2, 2016 | -6.70 Mn |